Mathematical techniques developed by computer pioneer Alan Turing could form the basis of a more reliable test for the early diagnosis cancer and other diseases, according to new research.
Work by the Second World War cryptographer – who famously cracked the German ‘Enigma’ code, arguably shortening the conflict – could help doctors in the emerging field of ‘precision medicine’, which aims to personalise treatments so that patients have a better chance of recovery.
Turing’s so-called ‘weights of evidence’ technique is superior to the existing C-statistic method – which has been used by researchers since the 1980s as the statistical model used to quantify the performance of a diagnostic test.
However, the C-statistic does not indicate how the diagnostic test would perform when used to ‘stratify people by risk’, Professor Paul McKeigue, of the University of Edinburgh’s Usher Institute of Population Health Sciences and Informatics, argues.
In a blog post attached to an article published in the Statistical Methods in Medical Research journal, he writes: “I propose an alternative approach based on estimating the weight of evidence. The background to this work lies in unpublished studies of Alan Turing, who in 1941 at Bletchley Park investigated the distribution of weights of evidence to decide the best strategy for breaking the ENIGMA code. Turing discovered some key properties of this distribution, which were extended in 1968 by his former assistant Jack Good, by then one of the most influential Bayesian statisticians of the 20th century.”
Turing’s method could be used to address two major challenges – how likely a person is to develop a disease, and whether or not a drug will work for them.
The development could improve on existing statistical tools that can assess the accuracy of diagnostic tests. They are unable currently to gauge how useful a test might be in determining a particular individual’s risk of developing a disease.
Researchers say existing methods are not useful for evaluating the likely impact of a new test compared with an old one. Neither are they effective at predicting how often the test will give wrong results in practice.
Working at Bletchley Park in 1941, Turing devised his method used to break the German forces’ Enigma code; the story was told in the 2014 Hollywood blockbuster The Imitation Game, starring Benedict Cumberbatch.
Turing worked out how the weight of evidence was expected to vary over repeated experiments. His ideas were developed further in 1968 and published by his former assistant Jack Good.
Professor Paul McKeigue, of the University’s Usher Institute of Population Health Sciences and Informatics, shows that the same principle of how the weight of evidence varies can be applied to evaluate the diagnostic tests used for personalised treatments. In this way, the performance of a test can be quantified.
He said “Most existing diagnostic tests for identifying people at high risk of cancer or heart disease do not come anywhere near the standards we could hope to see. The new era of precision medicine is emerging, and this method should make it easier for researchers and regulatory agencies to decide when a new diagnostic test should be used.”
Join FutureScot’s Digital Health & Care conference on November 27 to learn how healthcare data is being used to deliver innovative new services.
Related posts
Interviews
Comment
Why innovation and marketing are the perfect partners to make changes that matter
With the rapid evolution of traditional marketing and the appearance of digital marketing, technology and innovation has become part of any marketer’s life without the need of working for a…
Transitioning to a four-day week – CEO’s vow to strike a healthier balance in the workplace
I came to Scotland nearly 20 years ago from Ireland, with no contacts but a lot of determination. While Ireland will always be my home, Scotland has given me amazing…
Women Lead: The female-led company championing intuitive working
Over the last two years, the pandemic forced a shift to more remote and flexible working practices. Whilst we might be seeing a “return to normal”, some companies are choosing…
Women Lead: My passion for young people to consider a career in digital
Twenty years ago, I stumbled across my career in digital marketing almost by accident. It was during my honours degree in marketing at Glasgow Caledonian University. I was on work…
Women Lead: Inclusive Silicon Valley cohort gives hope to entrepreneurs from diverse backgrounds
Things are happening on the Scottish tech scene. Big and small initiatives are creating a fantastic ripple effect on the sector, bottom up and top down, thanks to the recommendations…
Women Lead: The story of an entrepreneurial scientist
I first arrived in Scotland over 20 years ago. I had £75 in my wallet and a scholarship offer to do a PhD at the University of Edinburgh. Sometimes I…
Please mind the gap… or healthcare may fall
Imagine sharing a lengthy train journey with others. From beginning to end, imagine how often you might hear ‘mind the gap’ messages about embarking and disembarking safely. Picture how navigating…
Women Lead: My journey from Dragons’ Den to Silicon Valley
Following her appearance on Dragons’ Den, Sheila Hogan, serial entrepreneur, founder and chief executive of digital legacy vault, Biscuit Tin, shares her experience of her time in the Den and…